₹2,204.60-37.05 (-1.65%)
17-Jan-2025₹2,206.25-37.70 (-1.68%)
17-Jan-2025BSE : 524742
NSE : CAPLIPOINT
Sector : Health care
ISIN Code : INE475E01026
Last Updated: 17-Jan-2025
Market Cap (₹ Cr) | 16,755 |
Traded Value (₹ Cr) | 1.29 |
Volume (Shares) | 5,872 |
Face Value (₹) | 2 |
52-Week High (₹) | 2,636.00 |
52-Week High Date | 27-Dec-2024 |
52-Week Low (₹) | 1,221.00 |
52-Week Low Date | 04-Jun-2024 |
All Time High (₹) | 2,636.00 |
All Time High Date | 27-Dec-2024 |
All Time Low (₹) | 0.18 |
All Time Low Date | 27-Feb-2002 |
₹Stock Market LIVE:Sensex down 200 pts at 79,000; India Dec Svcs PMI Final at 59.3, from 58.4 before
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 16,768 |
EPS - TTM (₹) [C] | 64.93 |
P/E Ratio (X) [C] | 33.98 |
Face Value (₹) | 2 |
Latest Dividend (%) | 125.00 |
Latest Dividend Date | 23-Sep-2024 |
Dividend Yield (%) | 0.23 |
Book Value Share (₹) [C] | 334.49 |
P/B Ratio (₹) [C] | 6.60 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
UTI-Small Cap Fund (G) | 96.80 | 3,87,119 | 2.05 |
UTI-Small Cap Fund (IDCW) | 96.80 | 3,87,119 | 2.05 |
UTI-Small Cap Fund - Direct (G) | 96.80 | 3,87,119 | 2.05 |
UTI-Small Cap Fund - Direct (IDCW) | 96.80 | 3,87,119 | 2.05 |
UTI-Aggressive Hybrid Fund (G) | 62.36 | 2,49,361 | 1.02 |
UTI-Aggressive Hybrid Fund (IDCW) | 62.36 | 2,49,361 | 1.02 |
UTI-Aggressive Hybrid Fund - Direct (G) | 62.36 | 2,49,361 | 1.02 |
UTI-Aggressive Hybrid Fund - Direct (IDCW) | 62.36 | 2,49,361 | 1.02 |
UTI-Large & Mid Cap Fund (IDCW) | 45.05 | 1,80,162 | 1.09 |
UTI-Large & Mid Cap Fund (G) | 45.05 | 1,80,162 | 1.09 |
Load more
Today's Low/High (₹) | 2,182.70 2,246.00 |
Week Low/High (₹) | 2,182.70 2,464.00 |
Month Low/High (₹) | 2,182.70 2,641.00 |
Year Low/High (₹) | 1,225.00 2,641.00 |
All time Low/High (₹) | 0.18 2,641.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -7.06% | -7.03% | -0.98 | -0.97% |
1 Month | -9.62% | -9.44% | -5.04 | -4.65% |
3 Month | 17.97% | 17.78% | -5.42 | -6.25% |
6 Month | 44.13% | 43.83% | -5.08 | -5.73% |
1 Year | 49.05% | 49.07% | 7.16 | 7.56% |
3 Year | 163.56% | 163.70% | 24.97 | 26.74% |
Chairman (Non-Executive) : C C Paarthipan
Independent Director : D Sathyanarayanan
Independent Director : C K Gariyali
Independent Director : Deenadayalan Singaram
Independent Director : R Nagendran
Managing Director : Sridhar Ganesan
Company Sec. & Compli. Officer : Venkatram G
Independent Director : R Vijayaraghavan
Registered Office: Ashvich Towers 3rd Floor, No 3 Developed Plots Ind Estat,Chennai,Tamil Nadu-600096 Ph: 91-44-24968000/71148000/28156653
1. What's the Caplin Point Laboratories Ltd share price today?
Caplin Point Laboratories Ltd share price was Rs 2,204.60 at close on 17th Jan 2025. Caplin Point Laboratories Ltd share price was down by 1.65% from the previous closing price of Rs 2,241.65. Caplin Point Laboratories Ltd share price trend:
2. How can I quickly analyse the performance of the Caplin Point Laboratories Ltd stock?
The performance of the Caplin Point Laboratories Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Caplin Point Laboratories Ltd?
Caplin Point Laboratories Ltd has a market capitalisation of Rs 16,755 crore.
4. What is Caplin Point Laboratories Ltd's 52-week high/low share price?
The Caplin Point Laboratories Ltd’s 52-week high share price is Rs 2,636.00 and 52-week low share price is Rs 1,221.00.
5. Is the Caplin Point Laboratories Ltd profitable?
On a consolidated basis, Caplin Point Laboratories Ltd reported a profit of Rs 105.74 crore on a total income of Rs 250.94 crore for the quarter ended 2024. For the year ended Sep 2024, Caplin Point Laboratories Ltd had posted a profit of Rs 130.81 crore on a total income of Rs 503.87 crore.
6. Which are Caplin Point Laboratories Ltd’s peers in the Health care sector?
Caplin Point Laboratories Ltd’s top 5 peers in the Health care sector are ERIS Lifescience, Neuland Labs., Astrazeneca Phar, Caplin Point Lab, Jubilant Pharmo, Sai Life, Granules India.
7. Who owns how much in Caplin Point Laboratories Ltd?
Key changes to the Caplin Point Laboratories Ltd shareholding are as follows: